Literature DB >> 8634087

Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.

M E Miele1, G Robertson, J H Lee, A Coleman, C T McGary, P B Fisher, T G Lugo, D R Welch.   

Abstract

Progression of human melanoma toward increasing malignant behavior is associated with several nonrandom chromosomal aberrations, most commonly involving chromosomes 1, 6, 7, 9, and 10. We previously showed that introduction of human chromosome 6 into the highly metastatic human malignant melanoma cell line C8161 completely suppressed metastasis without altering tumorigenicity (Welch DR, Chen P, Miele ME, et al., Oncogene 9:255-262, 1994). Alterations of chromosome 1 are the most frequent chromosome abnormality observed in melanomas, and they frequently arise late in tumor progression. The purpose of the study presented here was to compare the effects of chromosomes 1 and 6 on malignant melanoma metastasis. By using microcell-mediated chromosome transfer, single copies of neo-tagged human chromosomes 1 or 6 were introduced into the human melanoma cell line MelJuSo. The presence of the added chromosome was verified by G banding of karyotypes, fluorescence in situ hybridization, and screening for polymorphic markers on each chromosome. The incidence and number of metastases per lung after intravenous or intradermal injection of parental MelJuSo cells was significantly (P<0.01) greater than those of hybrids containing either chromosome 1 or chromosome 6, although chromosome 1 was a less potent inhibitor of metastasis than chromosome 6. Cultures established from primary tumors and metastases remained neomycin resistant, suggesting that portions of the added chromosomes were retained. These results strengthen the evidence for the presence of a melanoma metastasis suppressor gene on chromosome 6. neo6/MelJuSo hybrids expressed 2.4- to 3.4-fold more of the melanoma differentiation-associated gene mda-6 (previously shown to be identical to WAF1/CIP1/Sdi1/CAP20) than parental metastatic cells. mda-6/WAF1 is among the candidate genes on chromosome 6. These results also demonstrate, for the first time, the existence of metastasis suppressor genes on human chromosome 1, although these genes appear to be less potent than the one encoded on chromosome 6.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634087     DOI: 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  23 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

Authors:  Yeong-Gwan Park; Xiaohong Zhao; Fabienne Lesueur; Douglas R Lowy; Mindy Lancaster; Paul Pharoah; Xiaolan Qian; Kent W Hunter
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

3.  Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

Authors:  E Votsi; D Roussos; I Katsikis; A Karkanaki; M Kita; D Panidis
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

4.  GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1.

Authors:  Yee-Ming Chan; Sarabeth Broder-Fingert; Sophia Paraschos; Risto Lapatto; Margaret Au; Virginia Hughes; Suzy D C Bianco; Le Min; Lacey Plummer; Felecia Cerrato; Adelaide De Guillebon; I-Hsuan Wu; Fazal Wahab; Andrew Dwyer; Susan Kirsch; Richard Quinton; Timothy Cheetham; Metin Ozata; Svetlana Ten; Jean-Pierre Chanoine; Nelly Pitteloud; Kathryn A Martin; Raphael Schiffmann; Hetty J Van der Kamp; Shahla Nader; Janet E Hall; Ursula B Kaiser; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2011-08-31       Impact factor: 5.958

Review 5.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

6.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

7.  Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Authors:  M E Miele; A De La Rosa; J H Lee; D J Hicks; J U Dennis; P S Steeg; D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

8.  The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.

Authors:  M J Seraj; M A Harding; J J Gildea; D R Welch; D Theodorescu
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

9.  CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.

Authors:  Vladislava O Melnikova; Andrey S Dobroff; Maya Zigler; Gabriel J Villares; Russell R Braeuer; Hua Wang; Li Huang; Menashe Bar-Eli
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

Review 10.  Metastasis suppressor genes.

Authors:  Jinchun Yan; Qin Yang; Qihong Huang
Journal:  Histol Histopathol       Date:  2013-03       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.